Literature DB >> 23424115

Epigenomic model of cardiac enhancers with application to genome wide association studies.

Avinash Das Sahu1, Radhouane Aniba, Yen-Pei Christy Chang, Sridhar Hannenhalli.   

Abstract

Mammalian gene regulation is often mediated by distal enhancer elements, in particular, for tissue specific and developmental genes. Computational identification of enhancers is difficult because they do not exhibit clear location preference relative to their target gene and also because they lack clearly distinguishing genomic features. This represents a major challenge in deciphering transcriptional regulation. Recent ChIP-seq based genome-wide investigation of epigenomic modifications have revealed that enhancers are often enriched for certain epigenomic marks. Here we utilize the epigenomic data in human heart tissue along with validated human heart enhancers to develop a Support Vector Machine (SVM) model of cardiac enhancers. Cross-validation classification accuracy of our model was 84% and 92% on positive and negative sets respectively with ROC AUC = 0.92. More importantly, while P300 binding has been used as gold standard for enhancers, our model can distinguish P300-bound validated enhancers from other P300-bound regions that failed to exhibit enhancer activity in transgenic mouse. While GWAS studies reveal polymorphic regions associated with certain phenotypes, they do not immediately provide causality. Next, we hypothesized that genomic regions containing a GWAS SNP associated with a cardiac phenotype might contain another SNP in a cardiac enhancer, which presumably mediates the phenotype. Starting with a comprehensive set of SNPs associated with cardiac phenotypes in GWAS studies, we scored other SNPs in LD with the GWAS SNP according to its probability of being an enhancer and choose one with best score in the LD as enhancer. We found that our predicted enhancers are enriched for known cardiac transcriptional regulator motifs and are likely to regulate the nearby gene. Importantly, these tendencies are more favorable for the predicted enhancers compared with an approach that uses P300 binding as a marker of enhancer activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23424115      PMCID: PMC3581590     

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  25 in total

1.  Identification of transcription factor binding sites in the human genome sequence.

Authors:  Samuel Levy; Sridhar Hannenhalli
Journal:  Mamm Genome       Date:  2002-09       Impact factor: 2.957

Review 2.  Remote control of gene transcription.

Authors:  Adam G West; Peter Fraser
Journal:  Hum Mol Genet       Date:  2005-04-15       Impact factor: 6.150

Review 3.  Transcriptional regulatory elements in the human genome.

Authors:  Glenn A Maston; Sara K Evans; Michael R Green
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

4.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

5.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.

Authors:  Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

6.  Transcriptional genomics associates FOX transcription factors with human heart failure.

Authors:  Sridhar Hannenhalli; Mary E Putt; Joan M Gilmore; Junwen Wang; Michael S Parmacek; Jonathan A Epstein; Edward E Morrisey; Kenneth B Margulies; Thomas P Cappola
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

7.  A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly.

Authors:  Laura A Lettice; Simon J H Heaney; Lorna A Purdie; Li Li; Philippe de Beer; Ben A Oostra; Debbie Goode; Greg Elgar; Robert E Hill; Esther de Graaff
Journal:  Hum Mol Genet       Date:  2003-07-15       Impact factor: 6.150

8.  ChIP-seq accurately predicts tissue-specific activity of enhancers.

Authors:  Axel Visel; Matthew J Blow; Zirong Li; Tao Zhang; Jennifer A Akiyama; Amy Holt; Ingrid Plajzer-Frick; Malak Shoukry; Crystal Wright; Feng Chen; Veena Afzal; Bing Ren; Edward M Rubin; Len A Pennacchio
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

9.  Dissecting the regulatory architecture of gene expression QTLs.

Authors:  Daniel J Gaffney; Jean-Baptiste Veyrieras; Jacob F Degner; Roger Pique-Regi; Athma A Pai; Gregory E Crawford; Matthew Stephens; Yoav Gilad; Jonathan K Pritchard
Journal:  Genome Biol       Date:  2012-01-31       Impact factor: 13.583

10.  TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes.

Authors:  V Matys; O V Kel-Margoulis; E Fricke; I Liebich; S Land; A Barre-Dirrie; I Reuter; D Chekmenev; M Krull; K Hornischer; N Voss; P Stegmaier; B Lewicki-Potapov; H Saxel; A E Kel; E Wingender
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  2 in total

1.  Allele-specific enhancers mediate associations between LCAT and ABCA1 polymorphisms and HDL metabolism.

Authors:  Alicia D Howard; Xiaochun Wang; Megana Prasad; Avinash Das Sahu; Radhouane Aniba; Michael Miller; Sridhar Hannenhalli; Yen-Pei Christy Chang
Journal:  PLoS One       Date:  2019-04-30       Impact factor: 3.240

Review 2.  Next-generation sequencing and epigenomics research: a hammer in search of nails.

Authors:  Shrutii Sarda; Sridhar Hannenhalli
Journal:  Genomics Inform       Date:  2014-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.